Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for shingles pain sufferers: drug trial underway

NCT ID NCT06708416

Completed Symptom relief Sponsor: Ono Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study tests an experimental drug called ONO-1110 to see if it can safely reduce pain in people with postherpetic neuralgia, a type of nerve pain that persists after a shingles infection. About 140 Japanese adults with pain lasting at least 3 months will receive either the drug or a placebo. The main goal is to measure changes in average pain scores over 8 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTHERPETIC NEURALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neuralgia, Postherpetic postherpetic neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTHERPETIC NEURALGIA

Contacts and locations

Locations

  • Central Japan International Medical Center

    Gifu, Japan

  • Chutoen General Medical Center

    Shizuoka, Japan

  • Fukuoka Tokushukai Hospital

    Fukuoka, Japan

  • Fukuuchi Pain Clinic

    Tokyo, Japan

  • Fukuwa Clinic

    Tokyo, Japan

  • Futaki Skin Care Clinic

    Tokyo, Japan

  • Juntendo University Hospital

    Tokyo, Japan

  • Junwakai Memorial Hospital

    Miyazaki, Japan

  • Kamezawa Clinic

    Aichi, Japan

  • Kawasaki Municipal Hospital

    Kanagawa, Japan

  • Kimura Clinic

    Aichi, Japan

  • Konan Hidamari Pain Clinic

    Kanagawa, Japan

  • Medical Corporation Fujigaki Clinic

    Ōita, Japan

  • Medical Corporation Toyama Dermatology

    Miyazaki, Japan

  • Mitaka Pain Clinic

    Tokyo, Japan

  • Mito Saiseikai General Hospital

    Ibaraki, Japan

  • Morimoto Clinic

    Osaka, Japan

  • National Hospital Organization Hokkaido Medical Center

    Hokkaido, Japan

  • National Hospital Organization Kure Medical Center

    Hiroshima, Japan

  • Nishinomiya Municipal Central Hospital

    Hyōgo, Japan

  • Nishiogi Pain Clinic

    Tokyo, Japan

  • Nomura Dermatology Clinic

    Kanagawa, Japan

  • Osaka Medical and Pharmaceutical University Hospital

    Osaka, Japan

  • Osaka Metropolitan University Hospital

    Osaka, Japan

  • Shizuoka Rehabili Pain Clinic

    Shizuoka, Japan

  • Southern Tohoku General Hospital

    Fukushima, Japan

  • Tai Clinic

    Kanagawa, Japan

  • Tokyo-Eki Center-Building Clinic

    Tokyo, Japan

  • Yamanashi Prefectural Central Hospital

    Yamanashi, Japan

  • Yokohama City Minato Red Cross Hospital

    Kanagawa, Japan

  • Yuaikai Tomishiro Chuo Hospital

    Okinawa, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.